Analyzing Acacia Research (NASDAQ:ACTG) and ALT5 Sigma (NASDAQ:AIFC)

Acacia Research (NASDAQ:ACTG) and ALT5 Sigma (NASDAQ:AIFC) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares Acacia Research and ALT5 Sigma”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acacia Research	$285.23 million	1.55	$21.68 million	($0.15)	-30.27
ALT5 Sigma	$20.07 million	3.91	-$344.51 million	$0.42	1.33

Acacia Research has higher revenue and earnings than ALT5 Sigma. Acacia Research is trading at a lower price-to-earnings ratio than ALT5 Sigma, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

86.7% of Acacia Research shares are owned by institutional investors. Comparatively, 6.3% of ALT5 Sigma shares are owned by institutional investors. 1.7% of Acacia Research shares are owned by company insiders. Comparatively, 0.2% of ALT5 Sigma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Acacia Research and ALT5 Sigma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acacia Research	1	0	1	0	2.00
ALT5 Sigma	1	0	0	0	1.00

Acacia Research presently has a consensus target price of $6.00, suggesting a potential upside of 32.16%. Given Acacia Research’s stronger consensus rating and higher possible upside, research analysts clearly believe Acacia Research is more favorable than ALT5 Sigma.

Risk & Volatility

Acacia Research has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, ALT5 Sigma has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500.

Profitability

This table compares Acacia Research and ALT5 Sigma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acacia Research	-5.39%	0.44%	0.33%
ALT5 Sigma	-4,021.65%	-51.87%	-48.30%

Summary

Acacia Research beats ALT5 Sigma on 10 of the 14 factors compared between the two stocks.

About Acacia Research

Acacia is a publicly traded (Nasdaq: ACTG) company that is focused on acquiring and operating businesses across the industrial, energy and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.